Oral Tablet Immunotherapy for Allergic Rhinitis: Advancing Management in the Pediatric Setting Evaluation (ID: i885-16) Survey

1.Which of the following best describes your profession?(Required.)

Other (please specify)

2.Which of the following best describes your specialty?(Required.)

Pediatrics

Allergy

Internal Medicine/Primary Care/Family Practice

Other (please specify)

4.How many years have you been in practice?(Required.)

<1

1 to 10

11 to 20

>20

5.Which of the following best describes your practice setting?(Required.)

Private Practice/Office Setting

Group Practice

Urgent Care

Hospital Network

Institutional Setting (skilled-nursing facilities, correctional facilities)

Other (please specify)

6.After participating in this activity, how confident are you in the management of patients with AR in your practice?(Required.)

Very confident

Confident

Little confidence

No confidence

9.Which of the following best describes the impact of this activity on your performance?(Required.)

I gained new strategies/skills/information I will apply to my area of practice

I need more information before I can change my practice

My practice is already consistent with the information presented

This activity will not change my practice

10.How committed are you to making changes in your practice based on your participation in this activity?(Required.)

Very committed

Committed

Not committed

I do not plan to make changes

If not committed or do not plan to make changes, please indicate reason.

11.Which new strategies/skills/information will you apply to your area of practice? Please select all that apply.(Required.)

Cite planned changes in practice including more thorough assessment of pediatric patients with AR/C

Have improved knowledge of current recommendations for AR/C assessment and current landscape of symptom-relieving therapies

Describe the role of skin prick and sIgE testing in patient assessment and identify opportunities for utility in current practice

Be able to cite current unmet needs in the care of children and adolescents with AR/C

Discuss the role of allergy immunotherapy in patients with AR/C and differentiate between SCIT and sublingual tablet immunotherapy

Review current FDA-approval status and safety and efficacy data of sublingual tablet immunotherapies for patients with AR/C

Develop treatment plans that incorporate appropriate assessment for and utilization of sublingual tablet immunotherapy in appropriately identified children and adolescents with AR/C

Other (please specify)

12.What barriers do you see to making changes in your practice? Please select all that apply.(Required.)

Lack of knowledge regarding evidence-based strategies

Lack of convincing evidence to warrant change

Lack of time/resources to consider change

Insurance, reimbursement, or legal issues

Conflicting guidelines or evidence

Patient compliance and/or patient resource barriers

Other (please specify)

13.As a result of your participation in this activity, what is one change you are most likely to implement in your practice?

14.Please list any clinical issues/problems within your scope of practice you would like to see addressed in future educational activities for AR/C?

15.If you indicated that you perceived commercial bias or influence, please describe: